More News

24 Sep 2019 Anchiano Therapeutics Enters into An Exclusive Option To License Agreement for Novel Pan-RAS Inhibitor and PDE10/β-catenin Inhibitor Programs
24 Sep 2019 Clovis Oncology Acquires Rights to FAP-Targeted Radiopharmaceutical Program from 3B Pharmaceuticals
20 Sep 2019 Boehringer Ingelheim Partners with Inflammasome Therapeutics to Develop Novel Therapies for Patients with Retinal Diseases
19 Sep 2019 Allogene Therapeutics Enters Research Collaboration Directed at Enhancing Future Cancer Immunotherapies
19 Sep 2019 Y-Trap Enters Collaboration with Merck KGaA, Darmstadt, Germany, to Develop Novel Antibody-Ligand Traps for Immuno-Oncology
17 Sep 2019 Oncoheroes Biosciences Inc. and Boehringer Ingelheim International GmbH sign exclusive licensing agreement for volasertib
16 Sep 2019 Lundbeck to acquire Alder BioPharmaceuticals – a company committed to transforming migraine treatment and prevention – in a transaction valued at up to USD 1.95 billion net of cash
16 Sep 2019 Sanofi and Abbott partner to integrate glucose sensing and insulin delivery technologies to help change the way diabetes is managed
12 Sep 2019 Avalon Ventures and COI Pharmaceuticals Announce Acquisition of Sitari Pharmaceuticals by GSK
12 Sep 2019 Tubulis and Glycotope Announce Research and Feasibility Agreement for the Discovery of Antibody Drug Conjugates
10 Sep 2019 Genmab and Tempus Enter into Strategic Collaboration Agreement
10 Sep 2019 Flexion Therapeutics and Xenon Pharmaceuticals Announce Flexion’s Acquisition of an Investigational NaV1.7 Inhibitor for the Treatment of Post-Operative Pain
10 Sep 2019 Grünenthal and Mesoblast Enter Strategic Partnership for Europe and Latin America to Develop and Commercialise Innovative Cell Therapy for the Treatment of Chronic Low Back Pain
09 Sep 2019 Phio Pharmaceuticals Announces Research Collaboration with Carisma Therapeutics to Evaluate its Self-Delivering RNAi Technology to Enhance Macrophage-Based Adoptive Cell Therapy
09 Sep 2019 Alexion and BridgeBio Announce Japanese License Agreement for Eidos’ Transthyretin Amyloidosis (ATTR) Investigational Medicine
08 Sep 2019 RNA-Targeted Small Molecules: new report about hot area of emerging discovery technologies financed by excited investors and pharma partners
06 Sep 2019 IFM Therapeutics Announces Collaboration and Exclusive Option Agreement for cGAS/STING-Focused Subsidiary, IFM Due
05 Sep 2019 Schrödinger Announces Collaboration with AstraZeneca to Deploy Advanced Computing Technology for Drug Discovery
05 Sep 2019 Maruho and X-Chem Announce Drug Discovery Collaboration
04 Sep 2019 BioNTech Announces New Collaboration to Develop HIV and Tuberculosis Programs
04 Sep 2019 Boehringer Ingelheim Expands KRAS Cancer Program with Lupin’s Clinical Stage MEK Inhibitor Compound
03 Sep 2019 Vertex to Acquire Semma Therapeutics With a Goal of Developing Curative Cell-Based Treatments for Type 1 Diabetes
03 Sep 2019 Velabs Therapeutics announces strategic partnership with alytas therapeutics to develop a novel immune-based therapy for obesity
03 Sep 2019 Sandoz announces global deal to commercialize proposed biosimilar natalizumab, a key multiple sclerosis medicine
03 Sep 2019 RIKEN and Astellas Enter into Worldwide Exclusive Licensing Agreement for Artificial Adjuvant Vector Cell Technology in Oncology

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up